PO-0813 A Phase I/II Study of durvalumab and stereotactic radiotherapy in locally advanced pancreatic cancer. (April 2019) - Tuli, R.; Nisen, N.; Lo, S.; Placencio, V.; Gresham, G.; Hendifar, A.